44 research outputs found
STUDY OF THE CONTAMINATING MICROBIOTA OF OLD PAPER SUPPORTS
Biodeterioration has drawn the attention of different specialists who started to cooperate and to understand the need of joint research to have a picture as comprehensive as possible of the degradation agents and the measures that can be taken to salvage the heritage assets. This paper contains a description of the microbiota identified in two types of old paper supports part of a private collection from North Moldavia (Romania), namely a church book from the end of the 19th century for which the paper was obtained manually from textile fibres, and a book from 1870 with paper from cellulose pulp derived from wood. To the purpose of identifying the types of bacteria and fungi present on the supports examined, several comments were made related to the morphology of the colonies developed on the growth medium, which provided important indications for the determination based on the microscopical examination as well. Bacterial contamination (of the genera Bacillus, Clostridium, Pseudomonas and Micrococcus) was detected in most samples collected. The diversity of the fungi isolated from the paper supports (the genera Penicillium, Alternaria) is the result of the fact that since they are highly hygroscopic materials, they have the capability to retain water more easily, which stimulates fungal growth. The investigations made to determine the presence of microorganisms responsible for degradation and their identification allowed the discovery and acertainment of the real and justified need to find ways to prevent biodeterioration or to inactivate and destroy biodeteriogens by non-invasive, eco-friendly chemical and physical treatments
Comparison of the Efficiency of Three Types of Solar Collectors
Solar energy is one of the most abundant resources energy available in theĀ world. Solar collectors have evolved in the last decades, but still they havenātĀ reached very high efficiencies.
The collector efficiency is dependent on the temperature of the plate which inĀ turn is dependent on the nature of the fluid flow inside tube, solar isolation, ambientĀ temperature and top loss coefficient, the emissivity of the plate and glass cover.Ā This paper presents the test results of three different solar collectors and comparesĀ their efficiency
Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadRecently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not diagnosed and treated accordingly. CRS generally occurs with therapies that lead to highly activated T cells, like chimeric antigen receptor T cells or in the case of bispecific T-cell engaging antibodies. This, in turn, leads to a proinflammatory state with subsequent organ damage. To better manage CRS there is a need for specific therapies or to repurpose strategies that are already known to be useful in similar situations. Current management strategies for CRS are represented by anticytokine directed therapies and corticosteroids. Based on its pathophysiology and the resemblance of CRS to sepsis and septic shock, as well as based on the principles of initiation of continuous renal replacement therapy (CRRT) in sepsis, we propose the rationale of using CRRT therapy as an adjunct treatment in CRS where all the other approaches have failed in controlling the clinically significant manifestations.School of Doctoral Studies - Iuliu Hatieganu University
Romanian Government
Ion Chiricuta Oncology Institute Cluj Napoca
Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca
European Economic Spac
Overview of the Side-Effects of FDA- and/or EMA-Approved Targeted Therapies for the Treatment of Hematological Malignancies.
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadIn the last decade there has been tremendous effort in offering better therapeutic management strategies to patients with hematologic malignancies. These efforts have ranged from biological to clinical approaches and resulted in the rapid development of new approaches. The main "problem" that comes with the high influx of newly approved drugs, which not only influences hematologists that frequently work with these drugs but also affects other healthcare professionals that work with hematologists in patient management, including intensive care unit (ICU) physicians, is they have to keep up within their specialty and, in addition, with the side-effects that can occur when encountering hematology-specific therapies. Nonetheless, there are few people that have an in-depth understanding of a specialty outside theirs. Thus, this manuscript offers an overview of the most common side-effects caused by therapies used in hematology nowadays, or that are currently being investigated in clinical trials, with the purpose to serve as an aid to other specialties. Nevertheless, because of the high amount of information on this subject, each chapter will offer an overview of the side-effects of a drug class with each reference of the section being intended as further reading.
Keywords: hematological malignancies; life-threatening side-effects; novel therapies.MDPI A
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia
Funding Information: Adrian Bogdan Tigu and Catalin Constantinescu contributed equally to the current manuscript. Catalin Constantinescu is funded by an internal grant of the Iuliu Hatieganu University ā School of Doctoral Studies. David Kegyes is funded by an internal grant of the Iuliu Hatieganu University ā School of Medicine. Mareike Peters is funded by a national grant of the Romanian Society for Bone Marrow Transplantation. Ciprian Tomuleasa is also supported by a grant awarded by the Romanian National Ministry of Research, Innovation and Digitalization: PNāIIIāP4āIDāPCEā2020ā1118 within PNCDI IV, Projects for Exploratory Medicine; Projects for Exploratory MedicineāPCE 225/2021; as well as a national grant awarded to Young Research Teams (PNāIIIāPIā1.1āTEā2019ā0271 āāSupporting a team of young researchers to create an independent research program based on the use of Sleeping Beauty protocol f or the development of CAR T Cells ā SEATTLEā). Diana Gulei, Diana Cenariu, Adrian Bogdan Tigu, Jon Thor Bergthorsson and Victor Greiff are supported by an international collaborative grant of the European Economic Space between Romania and Iceland 2021ā2023: āCooperation strategy for knowledge transfer, internationalization and curricula innovation in the field of research education at the 3rd level of study āAURORA.ā Publisher Copyright: Ā© 2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.Acute megakaryoblastic leukaemia (AMkL) is a rare subtype of acute myeloid leukaemia (AML) representing 5% of all reported cases, and frequently diagnosed in children with Down syndrome. Patients diagnosed with AMkL have low overall survival and have poor outcome to treatment, thus novel therapies such as CAR T cell therapy could represent an alternative in treating AMkL. We investigated the effect of a new CAR T cell which targets CD41, a specific surface antigen for M7-AMkL, against an in vitro model for AMkL, DAMI Luc2 cell line. The performed flow cytometry evaluation highlighted a percentage of 93.8% CAR T cells eGFP-positive and a limited acute effect on lowering the target cell population. However, the interaction between effector and target (E:T) cells, at a low ratio, lowered the cell membrane integrity, and reduced the M7-AMkL cell population after 24āh of co-culture, while the cytotoxic effect was not significant in groups with higher E:T ratio. Our findings suggest that the anti-CD41 CAR T cells are efficient for a limited time spawn and the cytotoxic effect is visible in all experimental groups with low E:T ratio.Peer reviewe
A narrative review of central nervous system involvement in acute leukemias.
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadAcute leukemias (both myeloid and lymphoblastic) are a group of diseases for which each year more successful therapies are implemented. However, in a subset of cases the overall survival (OS) is still exceptionally low due to the infiltration of leukemic cells in the central nervous system (CNS) and the subsequent formation of brain tumors. The CNS involvement is more common in acute lymphocytic leukemia (ALL), than in adult acute myeloid leukemia (AML), although the rates for the second case might be underestimated. The main reasons for CNS invasion are related to the expression of specific adhesion molecules (VLA-4, ICAM-1, VCAM, L-selectin, PECAM-1, CD18, LFA-1, CD58, CD44, CXCL12) by a subpopulation of leukemic cells, called "sticky cells" which have the ability to interact and adhere to endothelial cells. Moreover, the microenvironment becomes hypoxic and together with secretion of VEGF-A by ALL or AML cells the permeability of vasculature in the bone marrow increases, coupled with the disruption of blood brain barrier. There is a single subpopulation of leukemia cells, called leukemia stem cells (LSCs) that is able to resist in the new microenvironment due to its high adaptability. The LCSs enter into the arachnoid, migrate, and intensively proliferate in cerebrospinal fluid (CSF) and consequently infiltrate perivascular spaces and brain parenchyma. Moreover, the CNS is an immune privileged site that also protects leukemic cells from chemotherapy. CD56/NCAM is the most important surface molecule often overexpressed by leukemic stem cells that offers them the ability to infiltrate in the CNS. Although asymptomatic or with unspecific symptoms, CNS leukemia should be assessed in both AML/ALL patients, through a combination of flow cytometry and cytological analysis of CSF. Intrathecal therapy (ITT) is a preventive measure for CNS involvement in AML and ALL, still much research is needed in finding the appropriate target that would dramatically lower CNS involvement in acute leukemia.
Keywords: Acute leukemias; central nervous system involvement (CNS involvement); clinical management; pathophysiology.Iuliu Hatieganu University-School of Doctoral Studies (PCD 2019-2021)
Romanian Government
Ion Chiricuta Oncology Institute Cluj Napoca
European Economic Spac
Substrate properties, forest structure and climate influences wood-inhabiting fungal diversity in broadleaved and mixed forests from Northeastern Romania
Aim of the study: The main objective of this study was to find the factors which best explains the wood-inhabiting fungal speciesā richness in beech and oak-dominated forests.
Area of study: We focused on broadleaved and mixed forests found in Northeastern Romania.
Materials and methods: 59 plots were randomly set up in broadleaved and mixed forest stands, in which vegetation structure, composition, and topoclimatic factors were quantified along with wood-inhabiting fungal richness. Generalized linear models were used to characterize relationship between fungal diversity and biotic and abiotic factors.
Main results: 374 taxa were identified, with numerous species found to cohabitate, the highest sharing being between Fine Woody Debris and Downed Coarse Woody Debris. The best predictors of total diversity were related to the substrate, management, stand structure, and macroclimate. Higher volumes of logs and large branches in various decay stages increased fungal richness. The same effect was found in diverse forests, with large snags. Macroclimate and topoclimate positively influenced diversity, through De Martonne Aridity Index and snow cover length, both indicating macrofungi preferences for higher moisture of substrate. Silvicultural interventions had an ambivalent effect to fungal diversity, phenomenon observed through stump numbers and proportion.
Research highlights: Particular environmental characteristics proved significantly important in explaining different wood-inhabiting fungal richness patterns. Substrate-related variables were the most common ones found, but they were closely linked to climate and forest stand variables